Understanding Cannabis Use in PD
Summary
Cannabis use among older adults in Canada is increasing. Our goal is to examine the current prevalence and pattern of cannabis use in patients with Parkinson’s disease.
Each study visit will have a duration of approximately 2 hours. You may choose to do the study visit in person or via videoconference Zoom. During the 2 hours of the study, you will be asked to complete several questionnaires and scales. These questions and scales will ask about your quality of life, motor and non-motor symptoms of Parkinson's disease. We will ask questions to understand the prevalence and pattern of cannabis use in PD.
Eligibility
Eligible gender: Male, Female, Transgender, Other
Eligible ages: 18 to 100
Accepts healthy participants: Yes
Inclusion criteria:
1) Any age diagnosed with PD at any stage of the disease
2) PwPD and cognitive impairment or dementia will be included if they are accompanied by a carepartner that can support them through the study visits and provide needed information as they may be at higher risk of experiencing complications or side effects related to the use of cannabis
Exclusion criteria:
No exclusion criteria for the participants of the study.
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
Dr. Veronica Bruno Movement Disorders Program Foothills Medical Centre, Area 3
Principal investigator:
Veronica Bruno
Clinical trial:
No
REB-ID:
REB22-0980